We have previously shown that downregulation of DCIR expression in DCs via gene gun-mediated delivery of Clec4a shRNA inhibits tumor growth and enhances CD8+ T cell immunity in the murine MBT-2 tumor model [7]. The gene discussed is CD8A; the disease is neoplasm.